Viral hepatitis screening guideline before biological drug use in rheumatic patients

Biological drugs (tumor necrosis factor inhibitors, rituximab, tocilizumab, abatacept, and tofacitinib) are important treatment alternatives in rheumatology, particularly for resistant patients. However, they may cause hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivation; for instance, H...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Rheumatol
Main Authors: Karadağ, Ömer, Kaşifoğlu, Timuçin, Özer, Birol, Kaymakoğlu, Sabahattin, Kuş, Yeşim, İnanç, Murat, Keser, Gökhan, Kiraz, Sedat
Format: Artigo
Sprog:Inglês
Udgivet: Medical Research and Education Association 2016
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042270/
https://ncbi.nlm.nih.gov/pubmed/27708965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.150072
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker